Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds

Circulation

Volumn 108, Issue 7, 2003, Pages 896-901

  Baber, Syed R ^b   Champion, Hunter C ^b   Bivalacqua, Trinity J ^b   Hyman, Albert L ^b   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

Enzymes; Lung; Prostaglandins; Rat; Thromboxane

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTANOID; THROMBOXANE A2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART CATHETERIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

ANIMALS; ARACHIDONIC ACID; BLOOD VESSELS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUNG; MEMBRANE PROTEINS; MODELS, ANIMAL; PHENYLACETATES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; VASCULAR RESISTANCE; VASOMOTOR SYSTEM;

EID: 0041431104     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000084536.87322.BB     Document Type: Article

References (29)

1. Samuelsson B, Goldyne M, Granstrom E, et al. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997-1029.
2. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971;231:232-235.
3. Hela T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992;889:7384-7388.
4. Feng L, Sun W, Xia W, et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys. 1993;307:361-368.
5. Kennedy BP, Chan CC, Culp SA, et al. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Conmum. 1993;197:494-500.
6. O'Neill G, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330:156-160.
7. De Witt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochem Biophys J. 1971;1083:121-134.
8. Fu J-Y, Masferrer JL, Siebert K, et al. The induction and suppression of prostaglandin H: synthase in human monocytes. J Biol Chem. 1990;265:16737-16740.
9. Smith WL, De Witt DL, Biochemistry of prostaglandin H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol. 1995;15:2179-2194.
10. Asano K, Lilly CM, Drazen JM. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am J Physiol. 1996;271:L126-L181.
11. Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120.
12. Watkins DN, Peroni DJ, Lenzo JC, et al. Expression and localization of COX-2 in human airways and cultured airway epithelial cells, Eur Respir J. 1999;13:999-1007.
13. Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance hemodynamics and vasoactive eicosanoids. J Pharmacol Eur Ther. 1999;289:735-741.
14. Ermert L, Ermert M, Goppelt-Struebe M, et al. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol. 1998;18:479-488.
15. Ermert L, Ermert M, Althoff A, et al. Vasoregulatory prostanoids generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. J Pharmacol Exp Ther. 1998;286:1309-1314.
16. Holtzmann MJ. Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am Rev Respir Dis. 1991;143:188-203.
17. Holtzman MJ. Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol. 1992;54:303-329.
18. Hyman AL, Mathe AA, Leslie CA, et al. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state. J Pharmacol Exp Ther. 1978;207:388-401.
19. Spannhake EW, Lemen RJ, Wegmann MJ, et al. Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J Appl Physiol. 1978;44:397-405.
20. Spannhake EW, Hyman AL, Kadowitz PJ. Dependence of the airway and pulmonary vascular effects of arachidonic acid upon route and rate of administration. J Pharmacol Exp Ther. 1980;212:584-590.
21. Hennan JK, Huang J, Barrett TD, et al. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation. 2001;104:820-825.
22. Niwa K, Haensel C, Elizabeth-Ross M, et al. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res. 2001;88:600-608.
23. Davis R, Brogden RN. Nimesulide: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1994;48:431-454.
24. Cullen L, Kelly L, Connor SO, et al. Selective cyclooxygenase-2 inhibition by nimesulide in man. J Pharmacol Exp Ther. 1998;287:578-582.
25. Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A. 1998;95:13313-13318.
26. Funk CD, Funk LB, Kennedy ME, et al. Human platelet/erythroleukemia cell prostaglandin G/H synthase. FASEB J. 1991;5:2304-2312.
27. Bauer AK, Dwyer-Nield LD, Malkinson AM. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000;21:543-550.
28. Wilborn J, De Witt DL, Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol. 1995;268:L294-L301.
29. Harris RC. Cyclooxygenase-2 inhibition and renal physiology. Am J Cardiol. 2002;89:10D-17D.